Anticardiolipin and/or anti-β2-glycoprotein-I antibodies are associated with adverse IVF outcomes

Objective The purpose of the study is to evaluate the effects of anticardiolipin (aCL) and/or anti-β2-glycoprotein-I (aβ2GPI) antibodies, namely antiphospholipid antibodies (aPL), on in vitro fertilization (IVF) outcomes. Materials and methods The study group comprised infertile women with aPL undergoing IVF-ET cycles. Controls were infertile women with tubal etiology without aPL. The impact of aPL on reproductive outcomes, such as oocyte quality, embryo quality, and implantation capacity, was compared between the study group and controls. Additionally, peripheral blood T cell subsets, such as T helper (Th)1, Th2, Th17, and T regulatory (Treg) cells and cytokines, were analyzed by the flow cytometry. Differences between the study group and controls were analyzed. Results A total of 132 infertile women, including 44 women with aPL, and 88 controls were sequentially recruited for this study. Women with aPL had lower numbers of total and perfect/available embryos and lower rates of MII oocytes, blastocyst formation, perfect and available embryos, implantation, clinical pregnancy, and take-home baby. Additionally, imbalanced Th1/Th2 and Th17/Treg ratios, significantly higher levels of serum IL-2, TNF-α, IFN-γ, and IL-17A, and a significantly lower serum IL-4 were noticed in women with aPL compared to controls. Conclusion Women with aPL such as aCL and/or aβ2GPI antibodies were associated with adverse IVF outcomes. Early screening for aPL and appropriate consultation for couples undergoing IVF should be considered. In addition, underlying immunopathology and inflammatory immune mechanisms associated with aPL should be further explored.

[1]  Wei-wei Ma,et al.  Serum antiphospholipid antibody status may not be associated with the pregnancy outcomes of patients undergoing in vitro fertilization , 2022, Medicine.

[2]  Fangting Lu,et al.  Anti-Ro/SSA and/or anti-La/SSB antibodies are associated with adverse IVF and pregnancy outcomes , 2021, Journal of Reproductive Immunology.

[3]  Shidou Zhao,et al.  Treg deficiency‐mediated TH1 response causes human premature ovarian insufficiency through apoptosis and steroidogenesis dysfunction of granulosa cells , 2021, Clinical and translational medicine.

[4]  D. Saadoun,et al.  Management of Antiphospholipid Syndrome , 2020, Biomedicines.

[5]  Hong Jin,et al.  T Cell Metabolism: A New Perspective on Th17/Treg Cell Imbalance in Systemic Lupus Erythematosus , 2020, Frontiers in Immunology.

[6]  G. Guyatt,et al.  2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases , 2020, Arthritis & rheumatology.

[7]  G. Espinosa,et al.  Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from the EUROAPS registry. , 2020, Rheumatology.

[8]  L. Sammaritano.  Antiphospholipid syndrome. , 2019, Best practice & research. Clinical rheumatology.

[9]  Qingwen Wang,et al.  Heparin and aspirin combination therapy restores T-cell phenotype in pregnant patients with antiphospholipid syndrome-related recurrent pregnancy loss. , 2019, Clinical immunology.

[10]  E. Matteson,et al.  The Epidemiology of Antiphospholipid Syndrome: A Population‐Based Study , 2019, Arthritis & rheumatology.

[11]  F. Cicuttini,et al.  Antiphospholipid syndrome: a clinical review , 2019, The Medical journal of Australia.

[12]  M. Ward,et al.  EULAR recommendations for the management of antiphospholipid syndrome in adults , 2019, Annals of the rheumatic diseases.

[13]  M. Nouri,et al.  T cell Subsets in Peripheral Blood of Women with Recurrent Implantation Failure. , 2019, Journal of reproductive immunology.

[14]  Jinfang Zhu.  T Helper Cell Differentiation, Heterogeneity, and Plasticity. , 2018, Cold Spring Harbor perspectives in biology.

[15]  S. Kim,et al.  Impact of presence of antiphospholipid antibodies on in vitro fertilization outcome , 2018, Obstetrics & gynecology science.

[16]  Y. Shoenfeld,et al.  Antiphospholipid syndrome , 2018, Nature Reviews Disease Primers.

[17]  Xuefeng Yu,et al.  Autoimmune thyroid diseases and Th17/Treg lymphocytes , 2018, Life sciences.

[18]  G. Espinosa,et al.  The antiphospholipid syndrome , 2021, Revista Colombiana de Reumatología.

[19]  K. McCrae,et al.  Diagnosis and management of the antiphospholipid syndrome. , 2017, Blood reviews.

[20]  A. Miki,et al.  Factors associated with adverse pregnancy outcomes in women with antiphospholipid syndrome: A multicenter study. , 2017, Journal of reproductive immunology.

[21]  Y. Shoenfeld,et al.  Association of serum autoantibodies with pregnancy outcome of patients undergoing first IVF/ICSI treatment: A prospective cohort study. , 2017, Journal of reproductive immunology.

[22]  Yun Feng,et al.  Follicular fluid cytokine composition and oocyte quality of polycystic ovary syndrome patients with metabolic syndrome undergoing in vitro fertilization , 2017, Cytokine.

[23]  F. Aranda,et al.  Pregnancy failure in patients with obstetric antiphospholipid syndrome with conventional treatment: the influence of a triple positive antibody profile , 2017, Lupus.

[24]  J. Kwak‐Kim,et al.  Humoral and cellular autoimmunity in women with recurrent pregnancy losses and repeated implantation failures: A possible role of vitamin D. , 2016, Autoimmunity reviews.

[25]  C. Stewart,et al.  The Multifaceted Actions of Leukaemia Inhibitory Factor in Mediating Uterine Receptivity and Embryo Implantation , 2016, American journal of reproductive immunology.

[26]  R. Levy,et al.  Antiphospholipid Antibodies and Antiphospholipid Syndrome during Pregnancy: Diagnostic Concepts , 2015, Front. Immunol..

[27]  C. Chighizola,et al.  Antiphospholipid antibodies and infertility , 2014, Lupus.

[28]  F. Del Porto,et al.  Prevalence of antiphospholipid antibodies in patients with sterility undergoing ‘in vitro’ fertilization , 2014, Lupus.

[29]  P. Ruiz-Limón,et al.  A prospective open-label pilot study of fluvastatin on proinflammatory and prothrombotic biomarkers in antiphospholipid antibody positive patients , 2013, Annals of the rheumatic diseases.

[30]  Bo Xu,et al.  A retrospective study on IVF/ICSI outcome in patients with anti-nuclear antibodies: the effects of prednisone plus low-dose aspirin adjuvant treatment , 2013, Reproductive Biology and Endocrinology.

[31]  A. Gilman‐Sachs,et al.  Management of Women with Recurrent Pregnancy Losses and Antiphospholipid Antibody Syndrome , 2013, American journal of reproductive immunology.

[32]  M. Bauer,et al.  Decreased Levels of Circulating CD4+CD25+Foxp3+ Regulatory T Cells in Patients with Primary Antiphospholipid Syndrome , 2013, Journal of Clinical Immunology.

[33]  Xinli Liu,et al.  Th1/Th2/Th17/Treg expression in cultured PBMCs with antiphospholipid antibodies. , 2012, Molecular medicine reports.

[34]  A. Gilman‐Sachs,et al.  An imbalance in interleukin-17-producing T and Foxp3⁺ regulatory T cells in women with idiopathic recurrent pregnancy loss. , 2011, Human reproduction.

[35]  Canquan Zhou,et al.  Impact of Anticardiolipin Antibody on the Outcome of In Vitro Fertilization and Embryo Transfer , 2011, American journal of reproductive immunology.

[36]  P. Meroni,et al.  Pathogenesis of antiphospholipid syndrome: understanding the antibodies , 2011, Nature Reviews Rheumatology.

[37]  ACOG Practice Bulletin No. 118: antiphospholipid syndrome. , 2011, Obstetrics and gynecology.

[38]  P. Meroni,et al.  Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? Yes (in some cases) , 2008, Internal and emergency medicine.

[39]  M. Gamerre,et al.  Antigenic Profile, Prevalence, and Clinical Significance of Antiphospholipid Antibodies in Women Referred for in Vitro Fertilization , 2007, Annals of the New York Academy of Sciences.

[40]  J. Wilczyński.  Th1/Th2 cytokines balance--yin and yang of reproductive immunology. , 2005, European journal of obstetrics, gynecology, and reproductive biology.

[41]  J. Kujovich.  The use of LMWH in pregnancies at risk: new evidence or perception? , 2005 .

[42]  Judith E. Cartwright,et al.  Maternal and neonatal hair mercury concentrations: the effect of dental amalgam , 2003, BJOG : an international journal of obstetrics and gynaecology.

[43]  J. Mcintyre.  Antiphospholipid Antibodies in Implantation Failures * , 2003, American journal of reproductive immunology.

[44]  I. Cooke,et al.  Profile of cytokine mRNA expression in peri-implantation human endometrium. , 1998, Molecular human reproduction.

[45]  L. Chamley,et al.  Antiphospholipid antibodies in women having in-vitro fertilization. , 1996, Human reproduction.

[46]  M. Zilberstein,et al.  Regulatory effect of antiphospholipid antibodies on signal transduction: a possible model for autoantibody-induced reproductive failure. , 1992, American journal of obstetrics and gynecology.